SciEngines GmbH, a Kiel, Germany, provider of a new platform for high performance computing, has received an undisclosed investment from High-Tech Gründerfonds and New Commercial Room.
By using a massively parallel field-programmable gate array (FPGA) based architecture, SciEngines enables its customers, including end users, bioinformatics service and solution providers, to use the computational performance of supercomputers in a standard PC’s form factor and power consumption.
High-Tech Gründerfonds is financing a new product line optimized for bioinformatics, which will be developed and brought to market under the brand RIVYERA.
Commenting on the round, Klaus Lehmann, Senior Investment Manager of the High-Tech Gründerfonds, was quoted as saying: “The team of SciEngines has shown that they are capable of developing high performance computers with their existing product line for cryptanalysis.
“The market of bioinformatics seems to fit perfectly to the upcoming products of SciEngines”.